The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Preventive Cardiology-Reference-Cited by-同舟云学术

The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Preventive Cardiology

Published:2023-03 Issue:2 Volume:17 Page:208-218
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Virani Salim S.^ORCID,Aspry Karen,Dixon Dave L.^ORCID,Ferdinand Keith C.,Heidenreich Paul A.,Jackson Elizabeth J.^ORCID,Jacobson Terry A.^ORCID,McAlister Janice L.,Neff David R.,Gulati Martha,Ballantyne Christie M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference68 articles.

1. Heart disease and stroke statistics-2022 update: a report from the American Heart Association;Tsao;Circulation,2022

2. High-intensity statin use among patients with atherosclerosis in the U.S;Nelson;J Am Coll Cardiol,2022

3. Heart disease and stroke statistics—2023 update: a report from the American Heart Association;Tsao;Circulation,2023

4. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial;Neaton;Arch Intern Med,1992

5. Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials;Lancet,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Closing the gap between guidelines and clinical practice for managing dyslipidemia: where are we now?;Expert Review of Cardiovascular Therapy;2024-09

2. Revealing the Potential of Lipidomics;Journal of the American College of Cardiology;2024-07

3. Applying the ABCs of Cardiovascular Disease Prevention to the 2023 AHA/ACC Multisociety Chronic Coronary Disease Guidelines;The American Journal of Medicine;2024-02

4. Obicetrapib as an Adjunct to Stable Statin Therapy in Japanese Subjects: Results from a Randomized Phase 2 Trial;Journal of Atherosclerosis and Thrombosis;2024

5. Reinstating LDL-C Measurement as a Quality Metric;JACC: Advances;2024-01